insights_auto
Bakit bumaba ang ALMKT 2.79%?
Tingnan ang Higit pang Detalyechevron_right
ALMKT:EPA
Mauna Kea Technologies SA
€0.087
arrow_downward
-2.79%(-0.0025) 1D
Nob 20, 5:35:11 PM GMT+1 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa ALMKT...
Buksan
€0.09
Mataas
€0.09
Mababa
€0.09
Mkt. cap
16.66M
Avg. na dami
406.96K
Dami
258.62K
P/E ratio
0.74
Mataas nang 52-wk
€0.23
Mababa nang 52-wk
€0.07
EPS
€0.12
Mga natitirang share
195.26M
Bilang ng mga empleyado
56
Buksan
€0.09
Mataas
€0.09
Mababa
€0.09
Mkt. cap
16.66M
Avg. na dami
406.96K
Dami
258.62K
P/E ratio
0.74
Mataas nang 52-wk
€0.23
Mababa nang 52-wk
€0.07
EPS
€0.12
Mga natitirang share
195.26M
Bilang ng mga empleyado
56
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
The Motley Fool
·
1 oras ang nakalipas
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
TradingKey
·
6 oras ang nakalipas
S&P 500 Falls Below 200-Day Moving Average: Buy-the-Dip Opportunity or Bear Market Warning?
Beinsure
·
15 oras ang nakalipas
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
StoneX
·
2 araw ang nakalipas
S&P 500, Nasdaq 100 Drive into Correction Territory
Profile
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Tungkol sa Mauna Kea Technologies SA
CEOSacha Loiseau
Mga Empleyado56
Itinatag2000
Headquarters-
SektorHealth Care
Industriya-
Websitemaunakeatech.com